Back to search
FDAFDA · Food and drugs·Recall number D-200-2013

CALCIUM GLUCONATE INJECTION, USP, 10% (100 mg/mL), 10 mL, Single Dose Vial, Rx only, For Direct Slow IV or IV Additive Use Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- Product Code 31110, NDC 63323-311-10

Published March 20, 2013 · Recall initiated: February 1, 2013

Summary

FDA records drug Class III recall D-200-2013, published March 20, 2013 and initiated February 1, 2013. Recalling firm: Fresenius Kabi USA LLC (FK USA); Status: Terminated; Reported quantity: 155,900 vials domestically; Lot: Lot 6004889, Expiration Date 10/2014. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Missing label

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA LLC (FK USA)
Distributor
Nationwide
Lot
Lot 6004889, Expiration Date 10/2014
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CALCIUM GLUCONATE INJECTION, USP, 10% (100 mg/mL), 10 mL, Single Dose Vial, Rx only, For Direct Slow IV or IV Additive Use Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- Product Code 31110, NDC 63323-311-10 recalled?

Yes. FDA published recall D-200-2013 on March 20, 2013. Reported hazard: Labeling: Missing label

What should I do if I have this product?

Voluntary: Firm initiated · Letter